About
About Tianjin TEDA Biomedical Engineering Company Limited
Tianjin TEDA Biomedical Engineering Company Limited, together with its subsidiaries, engages in the research, development, manufacture, and sale of biological compound fertilizer products in the People's Republic of China. It operates through Fertiliser Products, and AI health & elderly care products and services segments. The company's biological compound fertilizer products include active fertilizer, mixture with nitrogen, phosphorus, and potassium with various formulas. It also involved in the provision of integrated elderly and health care; elderly equipment leasing services; elderly-related products sales; warehousing services; processing and licensing of the fertiliser products; sales of gold products for elderly customers, such as gold amulets and bracelets; sales of chips and servers supporting healthcare solutions; research and development of elderly care business; and elderly care consulting, advisory, management, and assessment services. In addition, the company provides and licenses electroencephalography photography (EEG) diagnosis detection services and conducts EEG detection and diagnosis technology services. Further, the company engages in the research, development, manufacture, and application of biomedical science and technology projects; regional soil resources conditioning and remediation research services; provision of soil environmental quality standards research services; development and application of AI medical large model and MaaS platform; AI life and health project expansion; and data cleaning, database, and data intelligence analysis full-process data services. Tianjin TEDA Biomedical Engineering Company Limited was incorporated in 2000 and is headquartered in Tianjin, the People's Republic of China.
Visit company website
5 years, 5 months ago
Tianjin TEDA Biomedical Engineering Company Limited is currently in a long term uptrend where the price is trading 107.9% above its 200 day moving average.
From a valuation standpoint, the stock is 71.3% cheaper than other stocks from the Basic Materials sector with a price to sales ratio of 0.4.
Tianjin TEDA Biomedical Engineering Company Limited's total revenue rose by 58.5% to $118M since the same quarter in the previous year.
Its net income has increased by 54.5% to $-32M since the same quarter in the previous year.
Finally, its free cash flow fell by 99.2% to $-10M since the same quarter in the previous year.
Based on the above factors, Tianjin TEDA Biomedical Engineering Company Limited gets an overall score of 4/5.